一种新的药物重新定位方法,使用元路径通过层次注意力机制聚合
IEEE transactions on computational biology and bioinformatics
|December 3, 2025
概括
这项研究引入了一种新的方法,MPHAM,用于预测药物和疾病的关联. MPHAM通过使用层次关注机制来整合来自异质网络的元路径信息来提高准确性和可解释性.
科学领域:
- 生物信息学是一种生物信息学.
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
背景情况:
- 药物重新定位通过将现有药物重新用于新疾病,节省时间和成本,加速药物发现.
- 目前的药物疾病关联预测方法与复杂的语义斗争,缺乏可解释性.
- 整合异质生物数据对于提高预测准确性至关重要.
研究的目的:
- 提出一种新的方法,MPHAM,用于药物疾病关联预测.
- 通过聚合元路径信息来提高预测准确性和模型解释性.
- 有效地整合各种生物数据源.
主要方法:
- 建立了一个异质信息网络 (HIN),包括药物,蛋白质和疾病.
- 开发了一个基于元路径的功能融合策略,以捕捉复杂的节点语义.
- 采用分层的注意力机制来进行动态的元路径重量分配.
主要成果:
- 通过整合复杂的元路径信息,MPHAM有效地预测了药物疾病关联.
- 与五种最先进的方法相比,实现了更高的预测准确度.
- 案例研究证实了MPHAM对药物候选疾病关联的准确预测性能.
结论:
- MPHAM提供了一种有效和可解释的方法来预测药物与疾病的关联.
- 该方法成功地利用异质信息和元路径语义.
- MPHAM推进了药物重新定位策略,并加速了药物发现.
相关概念视频
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug-Receptor Interaction: Agonist
3.7K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.7K
Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Drug-Receptor Interaction: Antagonist
4.6K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
4.6K
Agonism and Antagonism: Quantification
948
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
948

